Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists
Yongkai
Cao
abc,
Ningning
Sun
b,
Jiumei
Zhang
c,
Zhiguo
Liu
d,
Yi-zhe
Tang
c,
Zhengzhi
Wu
*c,
Kyeong-Man
Kim
*b and
Seung Hoon
Cheon
*b
aIntegrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632, China
bCollege of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea. E-mail: kmkim@jnu.ac.kr; shcheon@jnu.ac.kr; Fax: +82 625302949; Fax: +82 625302911; Tel: +82 625302936 Tel: +82 625302929
cThe Fist Affiliated Hospital of Shenzhen University, Shenzhen 518035, China
dChemical Biology Research at School of Pharmaceutical sciences, Wenzhou Medical University, Wenzhou 325035, China. E-mail: szwzz001@163.com; Fax: +86 75525622938; Tel: +86 75525622938
First published on 11th September 2018
Abstract
Correction for 'Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists' by Yongkai Cao et al., Med. Chem. Commun., 2018, DOI: 10.1039/c8md00237a.
The authors regret the following errors in their manuscript: in the Abstract, in the sentence beginning ‘Molecular docking demonstrated…’, ‘Phe7.39’ should be changed to ‘Tyr7.35’. In section ‘2.4 Molecular basis of selectivity over D2R’, in the sentence beginning ‘Notably, the different orientations…’, ‘Phe365/429’ should be changed to ‘Tyr365/429’. In section ‘3. Conclusion’, in the sentence beginning ‘The different orientations…’, ‘Phe7.39’ should be changed to ‘Tyr7.35’.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2018 |